Is Adding IgM Antibody to Polymerase Chain Reaction Testing Useful for COVID-19 Travel Screening?

Xin Yi; Clarence W Chan; Kiang-Teck J Yeo

doi:10.1093/ajcp/aqaa270

Is Adding IgM Antibody to Polymerase Chain Reaction Testing Useful for COVID-19 Travel Screening?

Am J Clin Pathol. 2021 Feb 11;155(3):321-323. doi: 10.1093/ajcp/aqaa270.

Authors

Xin Yi¹, Clarence W Chan², Kiang-Teck J Yeo^{2

3}

Affiliations

¹ Department of Pathology and Genomic Medicine, Weill Cornell Medical College, Houston Methodist Hospital and Research Institute, Houston, TX.
² Department of Pathology, University of Chicago, Chicago, IL.
³ Pritzker School of Medicine, University of Chicago, Chicago, IL.

No abstract available

Keywords: COVID-19; Coronavirus; Double-negative test; IgM and IgG antibody; Nucleic acid test; Point-of-care test; RT-PCR; SARS-CoV-2; Travel screening.

Publication types

Editorial

MeSH terms

Antibodies, Viral / blood*
COVID-19 / blood
COVID-19 / diagnosis*
COVID-19 Nucleic Acid Testing*
COVID-19 Serological Testing / methods*
Communicable Diseases, Imported / prevention & control*
Humans
Immunoglobulin M / blood*
SARS-CoV-2
Travel Medicine / methods

Substances

Antibodies, Viral
Immunoglobulin M